首页> 外文期刊>Critical Reviews in Eukaryotic Gene Expression >The effects of colony-stimulating factor-1 (CSF-1) on the development of osteoclasts and their expression of tartrate-resistant acid phosphatase (TRAP) in toothless (tl-osteopetrotic) rats.
【24h】

The effects of colony-stimulating factor-1 (CSF-1) on the development of osteoclasts and their expression of tartrate-resistant acid phosphatase (TRAP) in toothless (tl-osteopetrotic) rats.

机译:集落刺激因子1(CSF-1)对破骨细胞的发育和抗酒石酸酸性磷酸酶(TRAP)的表达的影响(无骨(t1骨骨))。

获取原文
获取原文并翻译 | 示例
           

摘要

The osteopetrotic mutation toothless (tl) in the rat is characterized by a limited number of osteoclasts with reduced amounts and/or activity of tartrate-resistant acid phosphatase (TRAP). Treatment of tl/tl mutants with the cytokine colony-stimulating factor (CSF)-1 increases both osteoclast number and enzyme activity, consistent with a loss-of-function mutation in the CSF-1 gene recently detected in this mutant. We have pursued these observations to demonstrate that there is a dose-dependent increase in osteoclast number, but not to normal levels. Osteoclasts in CSF-1-treated tl/tl mutants are large, have well-developed clear zones and ruffled borders, and secrete TRAP into resorption lacunae. The expression of TRAP mRNA, protein, and enzyme activity per bone appear normal after CSF-1 treatment. However, in contrast to the predominantly apical intracellular distribution in normal osteoclasts, an enrichment of TRAP enzyme activity in osteoclasts of CSF-1-treated tl/tl mutants is observed in the basal part of the cell. Our observations suggest that the CSF-1-treated mutant bones contain an abundance of mature osteoclasts, actively expressing markers for osteoclasts such as TRAP, cathepsin K, and matrix metalloproteinase (MMP)-9. Accumulation of TRAP at the end of the endocytic pathway in mature osteoclasts formed during CSF-1 treatment suggests that the TRAP enzyme has a rapid turnover in these highly active cells and uses a transcytotic pathway.
机译:大鼠中的无骨骨突变(t1)的特征在于有限数量的破骨细胞,其抗酒石酸的酸性磷酸酶(TRAP)的量和/或活性降低。用细胞因子集落刺激因子(CSF)-1处理tl / tl突变体会增加破骨细胞数量和酶活性,这与最近在该突变体中发现的CSF-1基因的功能丧失突变一致。我们已经进行了这些观察,以证明破骨细胞数量呈剂量依赖性增加,但未达到正常水平。用CSF-1处理的tl / tl突变体中的破骨细胞很大,具有发达的透明区和皱纹的边界,并且将TRAP分泌到吸收性腔隙中。 CSF-1处理后,每个骨骼的TRAP mRNA,蛋白质和酶活性表达正常。然而,与正常破骨细胞中主要为顶端的细胞内分布相反,在细胞的基础部分中观察到了CSF-1处理的tl / tl突变体的破骨细胞中TRAP酶活性的富集。我们的观察结果表明,经CSF-1处理的突变体骨骼中含有大量成熟的破骨细胞,可以主动表达破骨细胞的标记物,例如TRAP,组织蛋白酶K和基质金属蛋白酶(MMP)-9。在CSF-1治疗期间形成的成熟破骨细胞中,内吞途径末端的TRAP积累表明,TRAP酶在这些高活性细胞中具有快速更新并使用跨细胞途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号